Conversations on Mental Health: Jodi Gilman, PhD, & The Center for Addiction Medicine
Mass General researchers are testing how medical marijuana usage impacts mental health outcomes.
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
NewsMay | 28 | 2021
We are committed to providing the care you need—and we are taking unprecedented steps to keep you safe.
Mass General researchers are testing how medical marijuana usage impacts mental health outcomes.
Mass General researchers are testing the psychedelic compound psilocybin as a therapeutic for treatment-resistant depression.
TEMPOS is a user-friendly rating scale that can be used to assess adherence to reporting recommendations.
Early and longer-lasting treatment reduces risk of substance use disorder most significantly.
Transitions can be hard for anyone, but new college freshmen who also need to make a plan for their mental health needs require a specific set of tools for coping with this important life milestone. Learn more about preparing for mental health challenges in college.
Following news of yet another potential surge in COVID-19 cases driven by the subvariant of Omicron, many people are facing an uncomfortable feeling: anger.